LEQEMBI HCP Website and Materials

My team designed, developed and deployed the LEQEMBI HCP website. Lecanemab (Leqembi®) is an IV treatment that removes beta-amyloid from the brain. The FDA has approved it for early Alzheimer's disease, including those with mild cognitive impairment or mild dementia linked to Alzheimer's, confirmed by high beta-amyloid levels. Leqembi lowers beta-amyloid and slows cognitive and functional decline in early Alzheimer's patients.
https://www.leqembihcp.com/